Clinical Trials Browser

Motor Activity × pembrolizumab × Dermatologic × Clear all

NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Phase EARLY_PHASE1 Active not recruiting

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT06627595 2024-11-15

APiTOXMM

Melanoma, Motor Activity